Supplementary Implants Supporting Conventional Removable Dental Prosthesis (RDPs) in Kennedy Class I

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Recruiting
CT.gov ID
NCT04276246
Collaborator
ITI International Team for Implantology, Switzerland (Other)
20
1
2
71.9
0.3

Study Details

Study Description

Brief Summary

In this study the additional effect of supplementary implants in patients with Kennedy Class I in terms of patient-reported outcome measures (PROMs) and cost-benefit-analyses comparing costs of maintenance care will be investigated

Condition or Disease Intervention/Treatment Phase
  • Device: dental implants and retentive implant components
  • Device: dental implants and supportive implant components
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Supplementary Implants Supporting Conventional RDPs in Kennedy Class I: A Dual-centered Randomized Controlled Trial
Actual Study Start Date :
Feb 6, 2020
Anticipated Primary Completion Date :
Feb 1, 2026
Anticipated Study Completion Date :
Feb 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental

All included participants receive each side 1 posterior implant in the edentulous areas bilaterally in Kennedy class I. Participants are provided with a conventional clasp retained removable partial denture (RPD) worn for 3 months. When implant osseointegration is ensured (3 months healing period), patients are assigned to retentive components (Group A, Test) which are connected to the implants to retain the RPD

Device: dental implants and retentive implant components
retentive components (Group A Test), which are connected to the implants to retain the RPD

Experimental: Control

All included participants receive each side 1 posterior implant in the edentulous areas bilaterally in Kennedy class I. Participants are provided with a conventional clasp retained removable partial denture (RPD) worn for 3 months. When implant osseointegration is ensured (3 months healing period), patients are assigned to supportive components (Group B, Control), which are connected to the implants to support the RPD

Device: dental implants and supportive implant components
supportive components (Group B Control), which are connected to the implants to support the RPD

Outcome Measures

Primary Outcome Measures

  1. Changes in patient-reported outcome measures (PROM) [assessment before implant placement, -1 week and 3 months after RPD insertion, 1 week and 3 months after connecting the implant components, 1 to 5 years after implant placement (5-year study period)]

    Assessment of patient's perception of function and oral health comparing conventional RPDs to implant-supported RPDs with and without retentive components in posterior sites of Kennedy Class I. PROMs are evaluated using the Oral Health Impact Profile (OHIP 14), i.e. the short form of OHIP with 14 items measuring oral health-related quality of life (OHQoL). The frequency of impairment in different areas (functional limitation, physical discomfort or disability, psychological discomfort or disability, social disability, and handicap) are indicated on a multi-level scale ("never"=0, "hardly"=1, "sometimes"=2, "often"=3, "very often"=4)

  2. Changes in chewing efficiency [assessment before implant placement, -1 week and 3 months after RPD insertion, 1 week and 3 months after connecting the implant components, 1 to 5 years after implant placement (5-year study period)]

    Assessment of the chewing Efficiency by masticating standardized fruit gum with three varying degree of hardness. A complete chewing function test comprises 9 chewing sequences: the different hardness of the model food is chewed once on the right, then on the left and finally on both sides. The study participants have 30 seconds for each chewing sequence and 30 seconds between each chewing sequence. Only one fruit gum is chewed per chewing sequence. The samples are placed on a defined area, photographed in standardized manner and analyzed with a computer program. The mean size and amounts of the chewed particles are calculated and determines the chewing efficiency

Secondary Outcome Measures

  1. prosthetic and implant survival rates [during follow-ups, 1 of 5 years after implant placement]

    prosthetic and implant survival rates (%) accounting for any technical and biological complication over 5 years

  2. cost-benefit-analyses [during follow-ups, 1 of 5 years after implant placement]

    cost-benefit-analyses over time, including costs during maintenance care during follow-up of 5 years will be conducted to compare test and control

  3. Evaluation of success of entire treatment [during follow-ups, 1 of 5 years after implant placement]

    evaluation of success of the entire treatment including assessments of technical (prosthesis adjustment or implant abutment adjustment or exchange) and biological complications (peri-implant diseases)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subjects must have voluntarily signed the informed consent before any study action, are willing and able to attend scheduled follow-up visits, and agree that the encoded data will be collected and analyzed

  • Males and females with at least 18 years of age

  • intraoral situation with bilateral edentulous areas located posterior to the remaining natural teeth (Kennedy class I) in the upper or lower jaw

  • remaining dentition includes a first premolar, canine or incisor as the most posterior tooth

Exclusion Criteria:
  • Uncontrolled systemic disease that would interfere with dental implant therapy;

  • Patients who smoke > 10 cigarettes per day or tobacco equivalents;

  • Patients with alcohol and/or drug abuse;

  • Patients with chronic pain;

  • Patients with untreated periodontitis and / or inadequate oral hygiene (Plaque Index < 30%);

  • Medical conditions requiring chronic high dose steroid therapy or anti-resorptive treatment;

  • Conditions or circumstances, in the opinion of the investigators, which would prevent completion of study participation or interfere with analysis of study results such as history of non-compliance or unreliability.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Reconstructive Dentistry, University Center for Dental Medicine Basel UZB, University of Basel Basel Switzerland 4058

Sponsors and Collaborators

  • University Hospital, Basel, Switzerland
  • ITI International Team for Implantology, Switzerland

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT04276246
Other Study ID Numbers:
  • 2019-02167; ex19Joda2
First Posted:
Feb 19, 2020
Last Update Posted:
Aug 5, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Basel, Switzerland

Study Results

No Results Posted as of Aug 5, 2021